Bevacizumab Injection
Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb)
Fully humanized monoclonal antibody biosimilar as a broad-spectrum antitumor drug
Bevacizumab（Arketin）, an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb), specifi_x005fcally binds to VEGF to prevent VEGF from binding to its receptor, thereby reducing neovascularization, inducing degeneration of existing blood vessels and inhibiting tumor growth. As a broad-spectrum anti-tumor agent, bevacizumab is a standard regimen recommended in treatment guidelines for various malig_x0002_nancies worldwide. Since entering the market, its efficacy and safety have been widely demonstrated in clinical practice.
Indications
Metastatic colorectal cancer; advanced, metastatic, or recurrent non-small cell lung cancer; recurrent glioblastoma; epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; and cervical cancer.
Recommended reading
How to choose a suitable bevacizumab biosimilar manufacturer?
Related products
-
Sungrow String Inverter SG 6.0 RS
Contact UsSuitable for 50Hz/60Hz grid, could be used in Asia, Africa,South America,Australia and Europe. Available for hand installation, no need for liftingmachinery assistance.
-
PGA Frac Ball
Contact UsPGA fully degradable frac plug ball is a series of frac plug balls developed based on PGA degradable materials to meet the needs of oil fields under various temperatures and working conditions.
-
JA Solar Deep Blue 4.0 600W 610W 620W 625W Bifacial Double Glass Modules
Contact UsModel NO:JAM78D40 600-625/GB
Weight:34.6 kg
Transport Package:Wooden Pallet and Carton Packing
Specification:2465±2mm*1134±2mm*35±1mm
Trademark:JA solar
Origin:China -
Infliximab for Injection
Contact UsEfficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
Reviews
There are no reviews yet.